1024. Evaluation of Atovaquone Prescribing for Pneumocystis jiroveci Pneumonia (PJP) Prophylaxis

Guidelines for the Prophylaxis of Pneumocystis jirovecii Pneumonia (PJP) in Children With Solid Tumors.

Although it is well-established that children undergoing allogeneic stem cell transplants and treatment for leukemia should be offered prophylaxis against Pneumocystis jirovecii pneumonia, the risk for children with solid malignancies is less certain. This guideline has been developed with the aim of standardizing practice and optimizing the benefit versus risk of prophylactic medication in thi...

Radiological presentation of Pneumocystis jiroveci pneumonia mimicking bacterial pneumonia.

To cite: Langevin B, Saleh M. BMJ Case Rep Published online: [please include Day Month Year] doi:10.1136/bcr-2016215207 DESCRIPTION Atypical radiological presentations of Pneumocystis jiroveci pneumonia have been previously reported in non-HIV as well as in HIV-infected patients. We present the case of a 64-year-old woman with a history of left upper lobe small cell lung cancer in radiological ...

Pneumocystis jiroveci pneumonia prophylaxis is a challenge in granulomatosis with polyangiitis patients treated with rituximab

Pneumocystis jiroveci

Pneumocystis jiroveci, formerly known as Pneumocystis carinii, is now believed to be a fungus. P. jiroveci pneumonia is a fungal infection, the primary symptoms of which include progressive dyspnea, nonproductive cough, and low-grade fever. These patients are often profoundly hypoxemic, and chest radiographs typically show bilateral, diffuse interstitial infiltrates. While P. jiroveci pneumonia...

Progression of Pneumocystis jiroveci pneumonia in patients receiving echinocandin therapy.

Echinocandins are a novel class of antifungal drugs that target beta (1, 3)-D-glucan synthesis. Animal studies have shown that these agents have activity against Pneumocystis jiroveci infection; however, clinical data are lacking. We reviewed all cases of proven P. jiroveci pneumonia (PCP) in non-human immunodeficiency virus-infected patients at our hospital over a 5 year period (2001-2005). Tw...